AnandRathi

Novelix Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
80.50
-0.35 (-0.43%)

Novelix Pharmaceuticals Ltd (Novelix Pharma.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹229 crore.

Novelix Pharmaceuticals Ltd Overview

Market cap₹229 Crs
Volume1,526
Prev. Close₹80.85
Year range₹38.00 - ₹92.00
Total Value₹1,22,843.00
ISININE314I01036

Novelix Pharmaceuticals Ltd Fundamental Analysis

ROCE(TTM)6.70%
P/E Ratio (TTM)63.39
P/B Ratio3.49
Debt to Equity0.09
ROE5.50%
EPS (TTM)1.27
Dividend Yield0.00%
Book Value23.08
Profit Margin2.46%
Operating Margin3.02%

Novelix Pharmaceuticals Ltd Historical Performance

1 Month Return9.67%
6 Month Return33.12%
3 Year Return791.47%
3 Month Return40.88%
1 Year Return95.39%
5 Year Return925.48%

Novelix Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research